Sponsor Pipeline

Nanjing RegeneCore Biotech Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07402551 Phase II Study of RC1416 Injection in COPD Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Recruiting
NCT07403487 Phase II Trial of RC1416 Injection in Asthma Moderate to Severe Asthma Not Yet Recruiting
Phase 1
NCT06756451 This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD… Hematologic Malignancies Recruiting
Disease Areas
COPD (1) Asthma (1)
Get alerts when Nanjing RegeneCore Biotech Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free